Navigation Links
Cardium's InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
Date:6/19/2008

on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities and Exchange Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.

Copyright 2008 Cardium Therapeutics, Inc. All rights reserved.

For Terms of Use Privacy Policy, please visit http://www.cardiumthx.com.

Cardium Therapeutics(TM) and Generx(TM) are trademarks of Cardium Therapeutics, Inc.

Tissue Repair(TM), Gene Activated Matrix(TM), GAM(TM) and Excellarate(TM) are trademarks of Tissue Repair Company.

InnerCool Therapies(R), InnerCool(R), Celsius Control System(TM), RapidBlue(TM), CoolBlue(TM) and Accutrol(TM) are trademarks of InnerCool Therapies, Inc.


'/>"/>
SOURCE Cardium Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
2. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
3. Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD)
4. Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
5. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
6. Fate Therapeutics Created by Leading Stem Cell Scientists to Pursue New Approaches to Stem Cell Therapies
7. Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer
8. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
9. Pipeline for Lung Cancer Therapies is Focus of New MedPredict Report
10. Teva Pharmaceuticals Altered Peptide Ligand Copaxone Boasts the Greatest Patient Share Among First- and Second-Line Therapies for the Treatment of Multiple Sclerosis
11. CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 27, 2015 /CNW/ - CQDM, Brain Canada and ... to six (6) multi-disciplinary and multi-provincial research teams across ... Focus on Brain strategic initiative. To this amount, $1.5M ... in-kind contributions. This exciting announcement was made today at ... in the presence of Inez Jabalpurwala, President and CEO ...
(Date:5/27/2015)... 2015 The ALS Therapy Development ... wholly owned subsidiary, Anelixis Therapeutics , $1.5 million ... that targets the innate immune system. The funding comes ... received from the 2014 social media phenomenon known as ... $4 million raised directly by the Institute through last ...
(Date:5/27/2015)... , May 27, 2015  CytomX, a biotechnology ... cancer, today announced the appointments of Bob ... Cynthia Ladd as senior vice president and ... chief financial officer of Onyx Pharmaceuticals, an Amgen ... consultant and legal counsel to several leading biotech ...
(Date:5/27/2015)...  Two years after its founding by a community ... Oakland -based Counter Culture Labs (CCL) ... to democratize science through a full-fledged community laboratory space ... Photo - http://photos.prnewswire.com/prnh/20150526/218366LOGO ... Based out of the new Omni Commons , ...
Breaking Biology Technology:Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 2Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 3Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 4Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 5Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 6Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 7Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 8Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 9Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 10Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 2Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 3CytomX Expands Executive Leadership Team 2CytomX Expands Executive Leadership Team 3East Bay's Counter Culture Labs Seeks to Open Doors of Science to Public 2East Bay's Counter Culture Labs Seeks to Open Doors of Science to Public 3
... New Rochelle, NY, February 8, 2011Successful intranasal delivery ... with Parkinson disease yielded significant improvement in motor ... the disease. These highly promising findings, reported in ... by Mary Ann Liebert, Inc. highlight the potential ...
... Feb. 16, 2011 Pneumococcus ( Streptococcus pneumoniae ... of mortality in young children worldwide. While successful ... only work against specific pneumococcal strains, with the ... emerge. Through a novel discovery approach, researchers at ...
... Pharmaceuticals, Inc. (Nasdaq: OPTR ) today announced ... of its common stock, including 900,000 shares sold pursuant ... granted to the underwriters. The shares were sold at ... in aggregate gross proceeds to Optimer of $77.6 million, ...
Cached Biology Technology:New Pneumococcal Vaccine Approach Successful in Early Tests 2New Pneumococcal Vaccine Approach Successful in Early Tests 3New Pneumococcal Vaccine Approach Successful in Early Tests 4Optimer Pharmaceuticals, Inc. Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock 2Optimer Pharmaceuticals, Inc. Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock 3
(Date:4/21/2015)... -- High crime rate, increasing government ... control systems market in Saudi Arabia ... report by TechSci Research " Saudi Arabia Access Control Systems Market ... market in Saudi Arabia is ... systems market in the Kingdom is growing at a ...
(Date:4/14/2015)... YORK , April 14, 2015  HYPR ... IDentity Online (FIDO ® ) Alliance tm , ... specifications. FIDO members commit to share technology and ... methods that are interoperable, more secure and private, ... enable biometric identity verification that protects sensitive user ...
(Date:4/10/2015)... April 10, 2015 Research and ... the "Security Competitive Profiles - NEC" report ... NEC will continue to supply a range ... market, with a company focus on the development of ... Winning opportunities in the Asia-Pacific ...
Breaking Biology News(10 mins):Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3NEC Security Competitive Profile 2015 2
... Seawater is a complex, dynamic mixture of dissolved ... best efforts, presents difficulties in measuring its potential ... itself, the calculations scientists employ to measure seawater ... the years as research techniques and instrumentation continues ...
... Baltimore, MDDouglas E. Koshland, staff scientist at Carnegie,s ... 72 Fellows by the American Academy of Microbiology. ... peer-review process, based on their records of scientific ... , Using the simple, single-celled yeast Saccharomyces ...
... Researchers have found evidence that a direct interaction between ... risk of developing multiple sclerosis (MS). The research, published ... Genetics , suggests that vitamin D deficiency during pregnancy ... the offspring developing MS later in life. MS ...
Cached Biology News:New equation of state of seawater 2New equation of state of seawater 3Carnegie's Doug Koshland elected Fellow of the American Academy of Microbiology 2Genetic study shows direct link between vitamin D and MS susceptibility 'gene' 2Genetic study shows direct link between vitamin D and MS susceptibility 'gene' 3
Rat Aortic Endothelial Cells (RAOEC) (>500,000 cells)...
... Precision Model 440 incorporates four channels of ... friendly easy-to-use instrument. Each channel consists of ... Bessel lowpass filter, a highpass filter, a ... A control knob sets the amplifier parameters ...
... The H2OBIT™ is a fully licensed, high ... simultaneous processing of up to 24 microplates. This ... 384-well plates. A robotic arm rapidly ... baths resulting in temperature ramping times that are ...
... a four-channel general purpose laboratory amplifier. It can ... which may have a large common-mode level and ... high gain/low noise amplifier, an input coupling selector, ... control. A control knob sets the amplifier parameters ...
Biology Products: